留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

新型胰岛分离液对小鼠胰岛分离效果的研究

李睿 董红丽 刘宝林

李睿, 董红丽, 刘宝林. 新型胰岛分离液对小鼠胰岛分离效果的研究[J]. 器官移植, 2018, 9(3): 188-193. doi: 10.3969/j.issn.1674-7445.2018.03.004
引用本文: 李睿, 董红丽, 刘宝林. 新型胰岛分离液对小鼠胰岛分离效果的研究[J]. 器官移植, 2018, 9(3): 188-193. doi: 10.3969/j.issn.1674-7445.2018.03.004
Li Rui, Dong Hongli, Liu Baolin. Study of isolation efficiency of new islet isolation solution for mouse islets[J]. ORGAN TRANSPLANTATION, 2018, 9(3): 188-193. doi: 10.3969/j.issn.1674-7445.2018.03.004
Citation: Li Rui, Dong Hongli, Liu Baolin. Study of isolation efficiency of new islet isolation solution for mouse islets[J]. ORGAN TRANSPLANTATION, 2018, 9(3): 188-193. doi: 10.3969/j.issn.1674-7445.2018.03.004

新型胰岛分离液对小鼠胰岛分离效果的研究

doi: 10.3969/j.issn.1674-7445.2018.03.004
基金项目: 

国家自然科学基金 30972908

辽宁省自然科学基金 2013021074

专利号 2013100320838

详细信息
    作者简介:

    李睿,男,1983年生,博士,主治医师,研究方向为胰岛移植,Email:lirui_83_10@163.com

    通讯作者:

    刘宝林,男,1966年生,博士后,主任医师,研究方向为胰岛移植,Email:liubl55@hotmail.com

  • 中图分类号: R617, R587.1, R458+.5

Study of isolation efficiency of new islet isolation solution for mouse islets

More Information
  • 摘要:   目的  探讨新型胰岛分离液(IPS液)在小鼠胰岛分离中的分离效率及胰岛保护作用。  方法  将消化后的小鼠胰腺按体积平均分为两组(IPS组和UW组),分别应用IPS-Optiprep液及UW-Optiprep液进行连续梯度密度离心分离胰岛,比较两组分离液的分离纯化效率和分离后的胰岛活性。将诱导成功的糖尿病小鼠随机分为3组:实验组(n=10),接受采用IPS-Optiprep液分离纯化的胰岛移植;对照组(n=10),接受采用UW-Optiprep液分离纯化的胰岛移植;假性移植组(n=5),仅给予手术但并不进行胰岛移植。分析3组小鼠术后血糖水平以及测实验组和对照组小鼠术后21 d的腹腔葡萄糖耐量试验的血糖水平。比较两种分离液的配制成本。  结果  与UW组相比,IPS组的IPS-Optiprep液可提供更高的胰岛当量(IEQ)、胰岛纯度、回收率及胰岛完整度。胰岛形态观察可见,IPS组胰岛被膜完整,直径明显大于UW组。UW组纯化后的胰岛活性率高于IPS组[(88±5)%比(84±3)%,P < 0.01]。与UW-Optiprep液相比,IPS-Optiprep液可获得相当的在体胰岛功能。IPS-Optiprep液可显著降低胰岛分离纯化成本。  结论  新型胰岛分离液IPS-Optiprep液在胰岛分离提纯中显示出较好的分离效率,增加了胰岛的纯度、完整度与回收率,并显著降低了纯化成本,但对胰岛细胞活性的保护作用稍逊,可能与胰岛的高完整度及IPS-Optiprep液中的内毒素有关。

     

  • 图  1  两组分离液分离纯化后的胰岛形态(双硫腙,×100)

    A图为经UW-Optiprep液纯化的胰岛;B图为经IPS-Optiprep液纯化的胰岛

    Figure  1.  Islets morphology after purification by isolation solution of two groups

    图  2  两组分离液分离纯化后的胰岛荧光图片(FDA/PI,×100)

    A图为经UW-Optiprep液纯化的胰岛;B图为经IPS-Optiprep液纯化的胰岛;红色荧光为死细胞,绿色荧光为活细胞

    Figure  2.  Fluorescence images of the purified islets by isolation solution of two groups

    图  3  3组糖尿病小鼠术后的血糖变化

    Figure  3.  Changes of blood glucose in diabetic mice of 3 groups after operation

    图  4  两组糖尿病小鼠胰岛移植后21 d腹腔葡萄糖耐量试验的血糖变化

    Figure  4.  Changes of blood glucose in diabetic mice of two groups by intraperitoneal glucose tolerance test at 21 d after islet transplantation

    表  1  两组分离液的胰岛分离纯化效率的比较

    Table  1.   Comparison of islet isolation and purification efficiency of isolation solutionbetween two groups (x±s)

    组别 纯化后IEQ 纯度(%) 完整度 回收率(%)
    IPS组 371±43 46±11 0.87±0.17 85±19
    UW组 285±47 33±60 0.70±0.15 65±15
    P < 0.01 < 0.01 < 0.05 < 0.05
    下载: 导出CSV
  • [1] SHAPIRO AM, RICORDI C, HERING BJ, et al. International trial of the Edmonton protocol for islet transplantation[J]. N Engl J Med, 2006, 355(13):1318- 1330. DOI: 10.1056/NEJMoa061267.
    [2] 王维.异种胰岛移植研究现状和走向临床的关键科学问题[J].器官移植, 2017, 8(6): 413-416. DOI: 10.3969/j.issn.1674-7445.2017.06.001.

    WANG W. Research status of islet xenotransplantation and key scientific problems toward clinic[J]. Organ Transplant, 2017, 8(6): 413-416. DOI: 10.3969/j.issn.1674-7445.2017.06.001.j.issn.1674-7445.2017.06.001.
    [3] JAMIOLKOWSKI RM, GUO LY, LI YR, et al. Islet transplantation in type I diabetes mellitus[J]. Yale J Biol Med, 2012, 85(1): 37-43. http://cn.bing.com/academic/profile?id=90b8bf7218e873a2879d420e27a77f0a&encoded=0&v=paper_preview&mkt=zh-cn
    [4] MERANI S, SHAPIRO AM. Current status of pancreatic islet transplantation[J]. Clin Sci (Lond), 2006, 110(6): 611-625. DOI: 10.1042/CS20050342.
    [5] KIN T. Islet isolation for clinical transplantation[J]. Adv Exp Med Biol, 2010, 654: 683-710. DOI: 10.1007/978- 90-481-3271-3_30.
    [6] NOGUCHI H, NAZIRUDDIN B, SHIMODA M, et al. Evaluation of osmolality of density gradient for human islet purification[J]. Cell Transplant, 2012, 21(2/3): 493- 500. DOI: 10.3727/096368911X605402.
    [7] MITA A, RICORDI C, MESSINGER S, et al. Antiproinflammatory effects of iodixanol (OptiPrep)- based density gradient purification on human islet preparations[J]. Cell Transplant, 2010, 19(12): 1537- 1546. DOI: 10.3727/096368910X516600.
    [8] LIU B, HAO J, PAN Y, et al. Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion[J]. Am J Transplant, 2006, 6(5 Pt 1): 933-946. DOI: 10.1111/j.1600-6143. 2006.01283.x.
    [9] 吴瑛, 张勇, 姚合斌.高脂联合小剂量链脲佐菌素建立实验性2型糖尿病大鼠模型[J].转化医学杂志, 2017, 6(6): 355-357. DOI:10.3969/j.issn.2095-3097.2017.06.009.

    WU Y, ZHANG Y, YAO HB. Study of streptozotocin and high-fat diet inducing type 2 diabetes in a rat model[J]. Translat Med J, 2017, 6(6): 355-357. DOI: 10.3969/j.issn.2095-3097.2017.06.009.j.issn.2095-3097.2017.06.009.
    [10] MCCALL MD, MACIVER AH, PAWLICK R, et al. Histopaque provides optimal mouse islet purification kinetics: comparison study with ficoll, iodixanol and dextran[J]. Islets, 2011, 3(4): 144-149. doi: 10.4161/isl.3.4.15729
    [11] DELLÊ H, SAITO MH, YOSHIMOTO PM, et al. The use of iodixanol for the purification of rat pancreatic islets[J]. Transplant Proc, 2007, 39(2): 467-469. DOI: 10.1016/j.transproceed.2007.01.039.
    [12] RIDGWAY D, MANAS D, SHAW J, et al. Preservation of the donor pancreas for whole pancreas and islet transplantation[J]. Clin Transplant, 2010, 24(1): 1-19. DOI: 10.1111/j.1399-0012.2009.01151.x.
    [13] BAERTSCHIGER RM, BERNEY T, MOREL P. Organ preservation in pancreas and islet transplantation[J]. Curr Opin Organ Transplant, 2008, 13(1): 59-66. DOI: 10.1097/MOT.0b013e3282f44a63.
    [14] HUANG GC, ZHAO M, JONES P, et al. The development of new density gradient media for purifying human islets and islet-quality assessments[J]. Transplantation, 2004, 77(1): 143-145. DOI: 10.1097/01.TP.0000100401.62912.B2.
    [15] LAU J, HENRIKSNÄS J, SVENSSON J, et al. Oxygenation of islets and its role in transplantation[J]. Curr Opin Organ Transplant, 2009, 14(6): 688-693. DOI: 10.1097/MOT.0b013e32833239ff.
    [16] UMEADI C, KANDEEL F, AL-ABDULLAH IH. Ulinastatin is a novel protease inhibitor and neutral protease activator[J]. Transplant Proc, 2008, 40(2): 387- 389. DOI: 10.1016/j.transproceed.2008.01.034.
    [17] NOGUCHI H, UEDA M, NAKAI Y, et al. Modified twolayer preservation method (M-Kyoto/PFC) improves islet yields in islet isolation[J]. Am J Transplant, 2006, 6(3): 496-504. DOI: 10.1111/j.1600-6143.2006.01223.x.
    [18] NOGUCHI H, UEDA M, HAYASHI S, et al. Comparison of trypsin inhibitors in preservation solution for islet isolation[J]. Cell Transplant, 2009, 18(5): 541-547. http://cn.bing.com/academic/profile?id=2237d5f01fed996142d2686b4026b62b&encoded=0&v=paper_preview&mkt=zh-cn
    [19] NOGUCHI H. Pancreas procurement and preservation for islet transplantation: personal considerations[J]. J Transplant, 2011: 783168. DOI: 10.1155/2011/783168.
    [20] BRISSOVA M, POWERS AC. Revascularization of transplanted islets: can it be improved?[J]. Diabetes, 2008, 57(9): 2269-2271. DOI: 10.2337/db08-0814.
  • 加载中
图(4) / 表(1)
计量
  • 文章访问数:  112
  • HTML全文浏览量:  43
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 收稿日期:  2018-01-21
  • 网络出版日期:  2021-01-19
  • 刊出日期:  2018-05-15

目录

    /

    返回文章
    返回